Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients).
The ideal partner for custom synthesis and contract manufacturing projects.

NEWS & EVENTS

OLON’S COMMITMENT IN ENERGY EFFICIENCY

December 06th, 2017
For several years Olon Settimo Torinese plant has been a partner in supplying thermal energy to the urban community heating network of Settimo Torines...
READ MORE
Olon on Pharma Horizon Magazine

October 2017
Not just a telling story... Click the image to read the full article
June 9th, 2017 - OLON acquired RICERCA

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA)Acquisition strengthens service offering of global CDMO and Gener...
READ MORE
If you need information, speak to one our experts.

FOCUS ON

Recombinant peptides

Olon has developed a recombinant peptide technology that allows to provide its customers with requested peptide on any scale.

Fluorination: a new technology

Olon with its brand new R&D Labs and Reactors for fluorination can now offer a full range of fluorinating processes under cGMP.